H

Harpoon Therapeutics

57 employees

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2015

Funding rounds raised

Total raised

$70M

from 14 investors over 14 rounds

H

Harpoon Therapeutics raised $70M on November 12, 2018

Investors: MPM Capital, NS Investment, Ridgeback Capital Management LLC, Lilly Asia Ventures, Arix Bioscience plc, OrbiMed Advisors, New Leaf Venture Partners and UBS Asset Management

H

Harpoon Therapeutics raised $45M on May 25, 2017

Investors: UBS Asset Management, MPM Capital, New Leaf Venture Partners and Arix Bioscience plc

H

Harpoon Therapeutics raised $15M on April 1, 2016

Investors: MPM Capital and UBS Asset Management

FAQ